Showing 154 results

Filters Content type: News, Editors' picks Topic: Bone & joint problems

Low bone mineral density (osteopenia) indicates that some bones are less dense than is normal. Having low bone mineral density doesn’t necessarily mean that you will develop osteoporosis or have a fracture.

Adherence

Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation

News
12 October 2016
Changing treatment

Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

Editor's pick
BETA blog
20 September 2016
PrEP

Bone loss and recovery in MSM aged 13-24 using PrEP for a year

Editor's pick
HIV i-Base
19 September 2016
PrEP science

Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most

News
26 July 2016
Side effects

Switching from tenofovir DF to TAF improves bone and kidney safety

News
11 July 2016
Ageing & HIV

Not So Fast: Do people with HIV really experience accelerated aging?

Editor's pick
Positively Aware
8 July 2016
Bone & joint problems

Fearing Drugs’ Rare Side Effects, Millions Take Their Chances With Osteoporosis

Editor's pick
New York Times
2 June 2016
Pharmaceutical industry

A question of timing: A lawsuit claims Gilead Sciences could have developed a less-harmful version of its HIV treatment sooner

Editor's pick
Los Angeles Times
30 May 2016
Bone & joint problems

HIV-infected young males have higher rates of bone loss than females

Editor's pick
Eurekalert Medicine & Health
11 March 2016
New & experimental HIV treatments

TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity

News
25 February 2016
PrEP science

Bone density recovers quickly after stopping PrEP

News
24 February 2016
Bone & joint problems

Tenofovir treatment raises the risk of broken bones

News
23 February 2016
Ageing & HIV

Free new tool for health providers to assist physical rehabilitation in people living with HIV

Editor's pick
Eurekalert Medicine & Health
2 December 2015
Bone & joint problems

START sub-study shows more bone loss with earlier HIV treatment

News
27 October 2015
New & experimental HIV treatments

Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety

News
25 October 2015
PrEP science

Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis

News
22 October 2015
Side effects

TAF and TDF Compared for Kidney, Bone Toxicity in Black HIV+ Patients

Editor's pick
Monthly Prescribing Reference
12 October 2015
Bone & joint problems

HIV Increases Bone Fracture Risk by 32% in Middle-Aged U.S. Women

Editor's pick
The Body
5 October 2015
Bone & joint problems

Bone loss slows, but continues long-term in HIV-positive people on antiretroviral therapy

News
14 September 2015
New & experimental HIV treatments

Tenofovir Alafenamide Combo Pill Matches Truvada for HIV Efficacy, but Easier on Bones and Kidneys

Editor's pick
HIVandHepatitis.com
4 September 2015
Changing treatment

Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health

News
28 July 2015
Bone & joint problems

ART: Daily Vitamin D and Calcium Stave Off Bone Loss

Editor's pick
Medscape
17 June 2015
PrEP science

Truvada PrEP causes only mild loss of bone mineral density

News
14 May 2015
Bone & joint problems

FRAX fracture prediction tool underestimates fracture risk in people with HIV

News
18 March 2015